Notice of Extraordinary General Meeting of Vitrolife AB (publ)

Rhea-AI Summary

Vitrolife AB has announced an Extraordinary General Meeting (EGM) for shareholders on October 20, 2021, with advance postal voting required. Shareholders must be registered by October 12, 2021, to participate. Key proposals include expanding the Board to six members, an increase in Board remuneration to SEK 2,440,000, and the election of Vesa Koskinen as a new Board member. Additionally, a non-cash issue of shares related to the acquisition of Igenomix will be proposed for approval.

Positive

• Election of Vesa Koskinen to the Board could enhance strategic direction.
• Expansion of the Board may lead to improved governance and decision-making.

Negative

• Increase in Board remuneration by SEK 275,000 could raise concerns among shareholders.

GOTHENBURG, Sweden, Sept. 29, 2021 /PRNewswire/ -- The shareholders of Vitrolife AB (publ) are hereby invited to the Extraordinary General Meeting of shareholders ("EGM") on October 20, 2021. The EGM will be held by advance voting (postal voting).

Shareholders who wish to attend the EGM must:

• be entered in the register of shareholders maintained by Euroclear Sweden AB on October 12, 2021 and                 
• notify their attendance by submitting their postal votes in accordance with the instructions in the Notice.

Shareholders that have their shares registered in the name of a nominee must temporarily record their shares in the share register kept by Euroclear Sweden AB in their own names to be able to attend the General Meeting.

The following proposals will be amongst those presented at the EGM:

• The Election Committee proposes that the Board should be extended with one Board member and consist of six Board members.
• Remuneration to the Board members is proposed to be SEK 2,440,000. The proposal entails an increase of SEK 275,000 due to the proposed increased number of Board members.
• The Election Committee proposes election of Vesa Koskinen, Partner and member of the global healthcare sector team at EQT, as a new Board member.
• The Board of Directors proposes that the General Meeting resolves to approve the Board's proposal on a new issue of shares (non-cash issue) related to the acquisition of Igenomix (see press release dated July 8, 2021).

Attachment: Full notice

Gothenburg, September 29, 2021
VITROLIFE AB (publ)
The Board

Contact:

Jón Sigurdsson, Chairman of the Board, email: jsigurdsson@ossur.com 

Mikael Engblom, CFO, phone +46 31 721 80 14

The information was submitted for publication, through the agency of the contact person set out above, at 10.00 am CET on September 29, 2021. 

This is a translation of the Swedish version of the press release. When in doubt, the Swedish wording prevails.

This information was brought to you by Cision http://news.cision.com

https://news.cision.com/vitrolife-ab--publ-/r/notice-of-extraordinary-general-meeting-of-vitrolife-ab--publ-,c3423494

The following files are available for download:

https://mb.cision.com/Main/1031/3423494/1474621.pdf

Notice to attend EGM 2021-10-20

View original content:https://www.prnewswire.com/news-releases/notice-of-extraordinary-general-meeting-of-vitrolife-ab-publ-301387556.html

SOURCE Vitrolife AB (publ)

FAQ

When is the Vitrolife AB Extraordinary General Meeting?

The Vitrolife AB Extraordinary General Meeting is scheduled for October 20, 2021.

How can shareholders vote for the EGM of Vitrolife AB?

Shareholders must submit their postal votes as detailed in the Notice to attend the EGM.

Who will be elected to the Board at the Vitrolife AB EGM?

The Election Committee proposes Vesa Koskinen as a new Board member.

What is the proposed increase in Board remuneration for Vitrolife AB?

The proposed remuneration for Board members is SEK 2,440,000, an increase of SEK 275,000.

What significant proposal will be addressed at the Vitrolife AB EGM?

The EGM will address the approval of a non-cash issue of shares related to the acquisition of Igenomix.